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Abstract 
The paper examines the Europeanization process and the impact of the European Union (EU) on 
national healthcare policies. The analysis reveals that although health policy formally falls within 
the competence of member states, the impact of the EU is becoming increasingly conspicuous and 
has contributed to a gradual restructuring of healthcare boundaries as well as some of its organising 
principles. Furthermore, the process and impact have a de-structuring effect on the more traditional 
governance tools used in relation to healthcare. The paper concludes that the EU has a significant 
impact and that we may be witnessing the formation of a new institutional legacy that represents the 
initiation of a Europeanised healthcare model: a model emerging around a new set of stakeholders, 
principles and structures, which include the market, principles of free movement, patient choice and 
patient rights institutionalised and safeguarded by the EU.  
 
 
1. Introduction 
This paper examines the impact of the European Union (EU) on Danish healthcare to identify the 
effect of the EU on a policy field which is formally regarded as falling within the realm of national 
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competence. In order to research impact, the study equally examines the process that has possibly 
Europeanised Danish healthcare policy.  
 
Strong national public policy traditions, encapsulated by national boundaries and an implicit 
subsidiarity organisation makes healthcare one of those policy fields where we should not expect 
significant Europeanization to take place. Healthcare constitutes a core aspect of the national 
welfare state in the individual EU member states. It is one of the welfare policy areas that has 
traditionally granted rights according to national citizenship, long-term residence or territorial 
principles. The principle of territoriality in welfare policies states that welfare benefits or services 
can only be consumed within the borders of the competent welfare institution. Such benefits or 
services cannot be exported beyond the national territory (Cornelissen 1996). Social sharing within 
healthcare has thus traditionally built on strong elements of ‘closure’ (Ferrera 2005). A main 
organising principle is that of boundaries mirroring the nation-state that are intended to shield the 
provision of healthcare within the national community. This structuring closure condition is 
challenged outright by European integration (Ferrera 2005; Bartolini 2005). As the analysis below 
demonstrates, EU integration represents a major challenge to welfare policies by virtue of the 
circumstance that it provides new exit and voice opportunities to the Union citizen (Hirschman 
1970; Ferrera 2005).      
 
The Europeanization of healthcare is the sum of a wide range of supranational interventions. 
According to the Treaty (article 152), the EU has no formal competence to regulate national 
healthcare. From the perspective of comparative politics, the Europeanization of healthcare 
constitutes a ‘critical’ or ‘less likely’ case. Strictly speaking, the case does not represent a ‘least-
likely’ case on the grounds that the free movement principles are constitutive for the EU and should 
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therefore also hold in relation to healthcare policy. However, it is a ‘less likely case’ for 
Europeanization, since the Treaty explicitly sets out that healthcare is a member state competence 
(for further discussion of the methodological and theoretical value of working with ‘least likely’ 
cases, see Eckstein (1975)). It is a critical case, because healthcare is formally regarded as a 
member state competence, where EU-induced change should not be expected. Furthermore, 
examining the meeting between EU principles and rules and the specific Danish case highlights the 
impact of the EU on systems organised as national health services (NHS), which in addition to 
Denmark counts the other Nordic member states, the UK, Ireland, Italy, Spain, Portugal and Greece. 
NHS systems were previously held to be sheltered from EU interference, as they offer healthcare as 
benefits-in-kind, free of charge, tax-financed and publicly supplied. Due to the characteristics of the 
national health service model, it was regarded as exempted from the Treaty’s understanding of 
‘service’ (Section 5 below).  
 
To the best of our knowledge, the impact of the EU on NHS systems has not previously been 
investigated in terms of process-tracing research from a political science and public administration 
perspective. The research for this paper includes different sets of interviews; 1) primarily with key 
respondents in the Danish Ministry of Interior and Health at several stages of the Europeanization 
process; 2) interviews conducted in the UK Department of Health to compare the findings of the 
Danish case; and 3) interviews in the European Commission, Unit of Coordination of Social 
Security. Furthermore, the research consists of documentary studies drawing on information from 
the archive of the Danish parliament in an attempt at quantifying the impact (see Section 3 below), 
parliamentary questions, debates and governmental notes. Both the interviews and the documentary 
study have served to separate national and EU influences on the identified healthcare reform 
process. On the basis of the research that has been carried out, the paper concludes that the EU is 
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having an increasing impact on the organisation and governance instruments of national healthcare 
– including those belonging to an NHS system – to the extent that it is possible to perceive a 
gradual restructuring of the contours and boundaries of healthcare as well as some of the organising 
principles and tools of governance.  
 
In addition to the introduction and conclusions, this paper consists of five substantive sections. In 
Section 2, we discuss theoretical issues that arise when researching the dynamics and impacts of 
Europeanization. Section 3 presents a quantitative examination of the impact. The subsequent 
sections examine the contemporary governance of Danish healthcare, focusing in particular on the 
issues of patient choice and free movement. Section 4 outlines the key characteristics of Danish 
healthcare and details recent reforms with relevance to EU integration. Section 5 describes the new 
external, i.e. EU-driven, boundaries to the policy field with specific focus on healthcare integration 
formed through the influence of the EU internal market; while Section 6 examines the 
Europeanization of Danish healthcare. Finally, some concluding remarks are presented about the 
Europeanization of Danish healthcare as the outcome of the interface between national and 
supranational processes of change.  
 
2. Researching the Dynamics and Impacts of the EU 
The study of Europeanization aims to understand and explain both the processes of change that 
national policies, politics and polities undergo as a result of EU integration together with the 
specific impact resulting from EU integration. According to the definition by Radaelli, 
Europeanization involves both a process through which formal and informal rules are first defined 
and consolidated at the EU level and then incorporated in the domestic discourse, political structure, 
and public policies (Radaelli 2003, p. 30; Bulmer & Radaelli 2005, p. 341). The focus of the present 
 5 
study concerns the Europeanization process and impact of European integration on national 
healthcare policy.  
 
However, it is important to set off by clarifying the European cause that drives Europeanisation 
(Smith 2002). Healthcare integration is characterised by a fragmented degree of coerciveness. As a 
field of integration, healthcare is institutionalised in a scattered way, in the sense that it lacks the 
binding knots of political commitments. However, it is a field of integration which demonstrates the 
powerful role of law in transcending high spirited, but inconcrete, principles, such as the free 
movement of services and Union citizenship, into effective tools of governance. Thus law, through 
the creative and teleological interpretations of the European Court of Justice, appears to be a 
functional tool in adding and expanding dimensions of the European polity (De Búrca 2005; Stone 
Sweet et al. 2001; Mattli and Slaughter 1998). Such neo-functionalist logic of extending the scope 
and meaning of the EU does, however, not tell us much about how this form of legal decision-
making is subsequently received nationally. The theoretical insights of Europeanisation studies are 
welcome supplements to better understand the complex dynamics of EU induced change.    
    
Previous studies of Europeanization indicate that mediating factors transmitting the Europeanization 
process are detrimental to the final impact of European integration on national policies. Mediating 
factors are explanatory variables which explain how the same independent variable, European 
integration, may have very different outcomes. These variables bring domestic factors back into 
focus. They cover a wide range of both national actors and institutions, including administrative 
capacity, national legacies, veto-points and cultures of compliance (Schmidt 2002; Haverland 2000; 
Börzel 1999, 2005; Falkner et. al 2005). Some may facilitate the process of Europeanization while 
others limit it.  
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The present study will identify two mediating factors which are decisive to the Europeanization of 
healthcare. The first constitutes a veto-point and is the way in which the national administration 
(re)interprets EU-relevant decisions for health. This veto-point limits Europeanization from the 
start, as it provides the national administration with interpretive discretion hindering the full impact 
of EU integration. However, the analysis will point out that such a veto-point is dynamic, and the 
national discretionary scope may narrow as EU integration continues. The second mediating factor 
concerns institutional legacy, but from the perspective of domestic reform. It thus opens up a 
dynamic perspective on institutional legacy, as even heavily institutionalised policies undergo 
change. In the present case, the domestic reform undertaken supports the principles in the 
integration process. Due to congruence between the steps of integration and those contained in the 
national reform, this mediating factor facilitates Europeanization. 
 
In general research, Europeanization is likely to be complicated by the fact that both independent 
and mediating variables are simultaneously in flux, i.e. it involves examining the effect of a 
dynamic cause transmitted by dynamic national institutions. In this way, Europeanization takes 
place as result of multiple influences rather than simply as a top-down EU-imposed or induced 
process of change.  
 
Figure 1: The Europeanization of Healthcare Policy 
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As Figure 1 illustrates, we expect a certain degree of institutional change to take place as a result of 
Europeanization. However, the extent and eventual further effect of EU-induced change will not be 
detailed here, but on the basis of the following analysis.    
 
This leads us to another challenge confronting the study of Europeanization: how do we measure 
the degree of change caused by European integration. For the future development of theory, it is 
essential that it is possible to measure the diverse impacts of the EU. Analysing the degree of 
European-driven change can be undertaken at a conceptual level – differentiating between 
retrenchment, inertia, absorption, accommodation and transformation, where the progression 
towards transformation signifies a greater degree of EU-induced change (Börzel 1999; 2005, pp. 
58-59; Radaelli 2003, pp. 37-40). Although such description remains at the conceptual level, it is 
useful for labelling degrees of change. Relying on the methodological characteristics of the present 
case as a ‘less likely’ case of Europeanization, we should either expect inertia or only a slight 
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degree of change; i.e. absorption. However, the mediating factors may propel or even retrench the 
effect of EU integration.  
 
The following analysis will first address whether the impact of the EU can be measured 
quantitatively. Subsequently, it will continue by conducting a qualitative process-tracing study.  
 
3. The Quantitative Measurement of Impact 
A precise and quantitative measurement of EU impact on specific policies would ideally serve the 
objective to ascertain the extent to which the EU reaches into the domestic realm. However, 
quantitative impact data are limited. Nevertheless, the archive of the Danish parliament makes it 
possible to quantify impact to some extent. Methodologically, we have examined the explanations 
attached to each legislative proposal on health policy in the archive of the Danish Parliament 
(Folketinget) to determine whether the proposal makes reference either to EU regulations or had 
been proposed in order to implement EU law. The archive provides data for the parliamentary years 
1997-2005. Our analysis only investigates those proposals which were later adopted by the 
parliament.  
 
Our dataset covers the Danish proposals which made reference to either EU ‘soft’ or ‘hard’ law, 
including measures beyond those that member states are legally bound to implement. Thus, the 
scope not only includes the laws that - partly or fully - aim to implement an EU directive, as well as 
those which simply refer to EU obligations in a broad sense. Implementation can be regarded as 
substantive Europeanization, whereas reference is likely to be largely formalistic. During the years 
covered in the data (1997-2005) approximately nine percent of the adopted proposals were 
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proposed in order to implement an EU directive, while around 23 percent made reference to EU 
regulation.  
 
The quantitative data show that between 1997 and 2005, an average of roughly 23 percent of 
Danish healthcare legislation was influenced by or referred to EU law. Figure 2 shows that the 
impact of the EU was greatest, at 33 percent, during both the 1998-1999 and 2000-2001 
parliamentary sessions and lowest during that of 1997–98, during which time none of the national 
laws adopted were influenced by EU rules.  
 
Figure 2: Danish healthcare legislation adopted with reference to EU regulation 
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Returning to substantive Europeanization, an average of nine percent of Danish healthcare 
legislation that represented the implementation of EU law is indeed considerable for a policy field 
which, formally regarded, is national competence. However, it may only mirror part of 
Europeanization. The dataset merely indicates those proposals that were introduced by legislation 
and does account for the EU regulations that the Danish Executive chose to introduce via 
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administrative means, such as departmental orders and circulars. Indeed, substantive 
Europeanization may be introduced via this route. Furthermore, the quantitative analysis leaves out 
all of the EU-related changes that were not the consequence of Community directives. This is 
because Treaty provisions and regulations have a direct effect and are therefore not normally 
implemented through the national legislative process. Furthermore, Community ‘decisions’ are also 
excluded, as they only regulate specific parties or situations. Finally, the impact of the ECJ case law 
may be dispersed, as it is not generally implemented via laws but may nevertheless have significant 
impact and influence on administrative practices, legal reasoning and future policy reform 
(Martinsen 2005).  
 
Other EU impacts may only be uncovered through a qualitative process-tracing study (Checkel 
2005), which we will now undertake, first by outlining the key characteristics of the Danish 
healthcare system, then by mapping the emerging contours of EU-driven developments in the policy 
field, and finally examining the Europeanization of Danish healthcare. 
 
4. Danish Healthcare; Characteristics and Recent Reforms  
Danish healthcare can be characterized as a decentralized, public, integrated healthcare system. 
Responsibility for organizing and delivering services is placed in the hands of 5 decentralized, 
democratically elected, assemblies at regional level, while the 98 municipalities have responsibility 
for an number of prevention and rehabilitation services. The system is integrated in the sense that 
both financing and delivering secondary level services are public responsibilities. Primary care 
services are provided by mainly private practitioners, but publicly funded and integrated in regional 
planning. The regions operate within a framework of national legislation and annual agreements 
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with the national level and biannual agreements with professional groups concerning financial 
arrangements and service delivery. 
  
The public healthcare system guarantees universal health coverage for all persons residing in 
Denmark. However, the general principle of territoriality implies that entitlement to Danish 
healthcare ends at the national border (Cornelissen 1996; Martinsen 2005).  
 
Treatment is provided free of charge and general practitioners serve as gate keepers to hospital 
services. There are co-payments, mainly for pharmaceuticals, dentistry and physiotherapy, but with 
exemptions for chronically ill and low-income groups. There is a strong emphasis on equity in 
terms of rights to the same treatment for the same condition, regardless of social status, age, 
geography or ability to pay. The system is financed through taxation (a fixed health contribution of 
8 percent of taxable income), which is redistributed to regional and municipal authorities as a 
combination of block grants and activity based contributions. Municipalities co-finance health 
services delivered by the regions.  
 
National policy reforms 
A number of changes have been implemented in the Danish healthcare system during recent 
decades. In general, they can be characterized as gradual adjustments rather than fundamental 
reforms (Pedersen et al 2005, Vrangbæk and Christiansen 2005). However, two trends with 
particular relevance for the analysis of Europeanization appear to have had a more profound impact 
over time. The first is the introduction of market elements and particularly patient choice, which is 
relevant for the discussion of free movement of goods, services and persons in the EU. The second 
is an ongoing trend toward centralization in both policy making and administration (Salomonsen 
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2005, Vrangbæk and Martinsen 2005). The centralization trend culminated in the decision on 
structural reform which was implemented January 1
st
 2007. The reform has changed the financing 
system (see above), has redistributed tasks and has reduced the number of regional authorities from 
14 counties to five regions (0,6-1,6 million inhabitants) and the number of municipalities from 275 
to 98 - with a population range from under 20,000 (less than seven percent of the new 
municipalities) to over 50,000 (37 per cent of the new municipalities). The centralization trend in 
Denmark (and other Nordic countries) is remarkable compared to decentralization trends in many 
other European health systems such as UK, Italy and Spain (Saltman, Bankauskaite and Vrangbæk 
eds. 2007).    
 
A choice of ‘insurance’ plan for access to general practice and specialists has been in place since 
the early 1970s. Most Danes choose ‘Group I’ coverage, which, once registered with a specific 
General Practitioner (GP), provides free GP and specialist services and GP controlled access to 
specialists and hospital treatment. Patients may change their GP registration at regular intervals, 
free of charge, or between periods for a nominal payment. ‘Group 2’ coverage provides direct 
access to specialists for a co-payment. This option is chosen by only around three per cent of the 
population.  
 
A policy providing a ‘free choice of hospital’ was introduced in 1993. Under this scheme a patient, 
once referred by a GP, may choose to have their treatment at any public hospital and some private 
not-for-profit hospitals at the same level of specialisation. An ‘extended free choice’ was introduced 
in 2002. This is linked to a treatment, or waiting time, guarantee and provides access to a range of 
contracted private and some foreign facilities, when patients are faced with an anticipated waiting 
time in the public health system that exceeds two months. The scheme is designed to increase the 
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service level by putting pressure on public providers, as the counties/regions are obliged to pay for 
services delivered in public or private hospitals outside their own jurisdiction. The waiting time 
guarantee institutionalizes the principle of access to private or foreign treatment facilities in cases of 
‘undue delay’ in the national system. The waiting time will be reduced to 1 month as of October 
2007. However, the Danish government maintains that the regions have the right to limit treatment 
abroad to selected facilities with which they hold a contract. This will be examined in more detail in 
section 6 below.  
 
There appears to have been a slightly increasing trend in the use of both types of choice. Official 
estimates show a growth in the share of non-acute patients treated outside their home county from 
eight per cent in 1997 to 11.3 per cent in 2003 (percentage of non-acute basic level patients treated 
in other counties as percentage of total number of non-acute basic level patients) (Indenrigs- og 
Sundhedsministeriet 2004). This study includes patients treated at higher levels of specialisation 
outside the county and referrals made in accordance with general agreements between counties, but 
excludes choices made inside counties. Use of ‘extended free choice’ to private and foreign 
treatment facilities is estimated at 1,7 per cent of all treatment episodes. The extended choice 
scheme is mainly used for eye surgery, orthopaedics, ear, nose and throat conditions and plastic 
surgery (Amtsrådsforeningen et al. 2004). 
 
The relatively limited use of the ‘free choice’ schemes reflects the generally short waiting times in 
Denmark, although variations in waiting times nevertheless persist. Preferences for treatment close 
to home, travel costs, custom and limited information on quality of provision may be other 
explanatory factors for the pattern of use (Vrangbæk et al. 2006; Vrangbæk 1999).  
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A Danish Diagnosis Related Groups (DRG) classification system for treatments and related pricing 
has been developed from the late 1990s. This has enabled a number of experiments with activity-
based financing as a supplement to the regular block grants and global budgets. ‘Free choice’ 
patients across county lines are paid on a full DRG price basis. In most cases this has created 
incentives for counties to try to retain patients by reducing waiting lists.  
 
In terms of healthcare policy debates, the role of the EU has so far been little debated. Adjustments 
to EU initiatives have mainly been treated as technical matters that have not given rise to major 
parliamentary or public debate. Within the health policy community some attention has been given 
to the development of the Service Directive, but as it became clear that this would not include 
healthcare the interest waned. Substantive EU impacts on healthcare have thus taken place rather 
discretely, insulated from wider debate.    
 
5. New external health boundaries 
At the same time as it undergoes domestic change, Danish health policy is increasingly affected by 
the initiatives and decisions of the European Union. National health policies are affected by EU 
intervention via different routes. While member state governments have for long held that they have 
full responsibility and control over their own health services, it is becoming increasingly clear that 
the Single European Market is having a substantial impact.  
 
Assessing the specific competencies of the EU within the area of health is a complex task. On the 
one hand, article 152 of the Treaty states that the EU has certain competencies in securing a high 
level of public health but at the same time caveats this that “Community action in the field of public 
health shall fully respect the responsibilities of the Member States for the organisation and delivery 
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of health services and medical care” (Article 152 (5) of the Treaty). On the other hand, the EU 
intervenes in a wide range of national health policies, through a patchwork of different regulatory 
principles and provisions consisting of Treaty provisions, regulations, directives, decisions and the 
case law of the ECJ. Article 152 of the Treaty provides legitimacy for a wide range of activities 
designed to improve public health. Furthermore, healthcare services are affected by the acquis 
concerning public procurement, health and safety, company law, insurance, and the internal market 
etc. Other areas are more directly affected. This is clear in relation to the provision of cross-border 
healthcare services; but other areas also directly affected are the organisation of working time (Dir. 
93/104/EC), health and safety, the movement of medical professionals (Dir. 93/16/EC), 
pharmaceuticals and medical equipment (see Permanand & Mossialos 2005).  
 
Perhaps most significantly, EU intervention in the field of healthcare has developed due to iterative 
interpretations of the principles of free movement, authoritatively led by the European Court of 
Justice. Until 1998, access to foreign healthcare providers in the EU was regulated solely through 
the system coordinating social security rights, which aims to promote the free movement of 
workers, and with the recent amendment, all persons (extended by Regulation 883/2004). The 
coordination system gave a nationally controlled possibility to take up health care abroad. The 
instrument of control was that of ‘prior authorisation’. European citizens were entitled to healthcare 
in other member states, provided that it had been authorised beforehand by the competent national 
institution.   
 
However, in a series of judgement from 1998 and onwards, the ECJ has questioned the justification 
for ‘prior authorisation’ and has gradually established that the principles of the internal market also 
apply to health policy (see Martinsen 2005b for a more detailed describtion of the series of 
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judgements). The Court first laid down that healthcare is a service within the meaning of the Treaty 
(C-120/95, Decker & C-158/96, Kohll, 28 April 1998). It later repeated that prior authorisation 
constitutes a barrier to the free movement of services, but may however be justified provided that 
(C-157/99 Geraets-Smits & Peerbooms, 12 July 2001): 
 
 The decision on whether or not to grant treatment abroad is based on “international medical 
science”; 
 And an equivalent treatment can be provided in the competent member state without “undue 
delay” taking into consideration the medical condition of the patient, broadly defined.  
 
The ECJ later proceeded with its proactive course by introducing a distinction between hospital and 
non-hospital care (C-385/99, Müller-Fauré & Van Riet, 13 May 2003). In the case of hospital care, 
the Court restated its view that the requirement for prior authorisation is justified on condition that it 
is exercised proportionately and that a national treatment can be provided without ‘undue delay. 
The matter was, however, quite different for non-hospital care. The Court laid down that national 
authorisation constitutes an unjustified barrier to the free movement of services for non-hospital 
care. Given the increasingly blurred distinction between hospital and non-hospital care, the future 
implications of this judgement are likely to be extensive. In 2006, a new contribution to the 
integration of healthcare was produced. In the recent case of Watts, the Court applied its line of 
reasoning to a National Health system, and considered for the first time the free movement of 
services principle against a health system providing treatment free of charge, publicly organised and 
funded through general taxation (C-372/04, Watts, 16 May 2006).  
 
The European Patient in Focus  
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On 16 May 2006, the ECJ’s long-awaited conclusions in the Watts case were made public. for the 
first time, the ECJ considered the implications of the logic of the internal market, for member states 
that otherwise separate the provision of healthcare from market considerations.  
  
The case concerned a hip replacement needed by Mrs. Yvonne Watts, a resident in the United 
Kingdom. Mrs. Watts requested authorisation to receive treatment abroad, not accepting a waiting 
time for treatment in the UK for initially 1 year, later reduced to three to four months. Despite the 
later  reduction in waiting time, Mrs. Watts went to France to have her hip replacement and, on her 
return, requested reimbursement of her costs of £ 3,900. That request was rejected by the English 
High Court, which argued that the reduction in her waiting time would have meant that Mrs. Watts 
would have been treated without ‘undue delay’. Mrs. Watts took her case to the Court of Appeal 
which, in turn, referred a long list of questions to the ECJ.  
 
In its judgement, the ECJ confirms, and indeed furthers, its previous line of health related 
judgements. The conclusions remove the scope for national institutions to exercise administrative 
discretion and bring the rights of the European patient into sharper focus. In so doing, it intervenes 
in the national sphere of governance. Furthermore, the Court equips the European patient with 
institutional structures to claim those rights. It frames the right to appeal.  
 
The Court repeated that all medical services are ‘services’ within the meaning of the Treaty:  
 
“It should be noted in that regard that, according to settled case-law, medical services provided for consideration 
fall within the scope of the provisions on the freedom to provide services […] there being no need to distinguish 
between care provided in a hospital environment and care provided outside such an environment (para 86 of the 
judgment).  
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The Court thus clarified that the characteristics of the UK National Health Service do not exempt it 
from EC law. Article 49 of the Treaty applies regardless of the way the national system is organised 
(para 90 of the judgement). The general applicability of the Court’s previous judgements is 
affirmative.  
 
The central issue being that of waiting time, it is crucial to note that although the Court does not 
specify when a waiting time for a particular treatment can be considered to be ‘undue delay’, it sets 
out a (reviewable) criterion for determining whether a period of waiting time is acceptable in the 
context of EC law. Waiting time must not: 
 
“exceed the period which is acceptable on the basis of an objective medical assessment of the clinical needs of the 
person concerned in the light of all of the factors characterising his medical condition at the time when the request 
for authorisation is made or renewed, as the case may be” (para. 79 of the judgement). 
 
The Court went on to specify the institutional structures that member states must provide to protect 
the rights of the European patient. The Court repeats the conclusions from its previous judgements, 
stating that the requirement for prior authorisation cannot legitimise discretionary decisions by 
national authorities, but must be based on objective, non-discriminatory, criteria and allow for 
decisions on authorisation to be challenged in judicial or quasi-judicial proceedings (paras. 115-
116). Notably, the Court goes beyond a restatement of precedent and extends member states’ 
obligation to provide transparency and legal certainty to European citizens:  
 
“To that end, refusals to grant authorisation, or the advice on which such refusals may be based, must refer to the 
specific provisions on which they are based and be properly reasoned in accordance with them. Likewise, courts 
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or tribunals hearing actions against such refusals must be able, if they consider it necessary for the purpose of 
carrying out the review which it is incumbent on them to make, to seek the advice of wholly objective and 
impartial independent experts” (para 117 of the judgement).   
 
The Watts case is a further judicial step strengthening the position of the European patient. Not only 
has s/he been granted rights beyond the national borders, but s/he has also been provided with a 
structure and judicial procedures through which to bypass the national system or challenge its 
decisions. In essence, the judicial activism of the ECJ has provided the Union citizen with new exit 
but also new voice opportunities beyond the national system. The response to this judgement by EU 
citizens, private interests, national courts and member state governments will decide the next steps 
in the further development of patients’ rights and the structures to guarantee them. Also the 
politicians and stakeholders have through the Commission’s open consultation procedure, running 
September 2006- January 2007, been granted the opportunity of voice. Many opinions have been 
formulated, and the next step is for the Commission to take. Throughout 2007, the Commission will 
work on the formulation of a Community proposal on patient mobility (interview, European 
Commission, February 2007), which, hopefully, will reintroduce some political direction and 
vision.  
 
6. The Europeanization of Danish Healthcare 
The impact of the judicial interpretations of the principles of the internal market on Danish health 
policy, while clearly visible, can be described as diffuse and restrained. Denmark is one of the 
member states, which has responded to the development of caselaw by partially integrating the 
foreign supply of goods and services. This implementation has effectively broken down the 
principle of territoriality in healthcare.  
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The Danish government was first alerted to the direction that EU policy was taking by the Decker 
and Kohll judgements. The judgements contradicted the then current view that internal market rules 
had no impact on health benefits and services - which caused considerable consternation among 
Danish health authorities. As a consequence, the government set up an inter-ministerial working 
group to analyse the implications of the judgments for Danish health policy. The working group 
reported that the Decker/Kohll rulings contained general premises that took the scope of the 
judgements beyond the lawsuits themselves. Thus, Denmark acknowledged that the cases had 
implications for healthcare systems other than that of Luxembourg and were not limited to glasses 
and dental treatment (Danish Report on the Decker/Kohll rulings 1999, p. 22). The Danish report, 
however, contained a narrow definition of what constitutes a ‘service’. To be a service according to 
the meaning of Treaty Article 50 (ex. Article 60), the Danish executive argued that there needs to be 
an element of remuneration involved:  
 
“It is the view of the working group that if, on the other hand, the treatment had been taken care of by the public 
hospital sector, the Treaty’s Article 49 would not have applied. The reason is that Article 50 defines services as 
services normally carried out in return for remuneration [...]Characteristic for a service is thus that a service 
provider offers a service in return for remuneration” (Danish Report on the Decker/Kohll rulings 1999, p. 23. 
Own translation, emphasis added). 
 
Denmark’s (re-)interpretation of the concept of ‘service’ meant, perhaps not surprisingly, that the 
large majority of Danish healthcare services fell outside that definition, since they are provided as 
benefits in kind, free of charge and thus with no direct remuneration. Thus, while Denmark had 
conceded that Decker and Kohll had an impact, the national definition of what constituted a service 
within the meaning of the Treaty allowed for the exemption of the entire public hospital sector, as 
well as all types of non-hospital care provided free of charge.  
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However, in acknowledging that the principles of the internal market – under certain conditions – 
apply equally to healthcare services, the interpretation of the working group marked a decisive 
break with the then current Danish view. This decisive break meant that healthcare services for 
which insured persons themselves paid one part and the competent institution the other, were 
considered to fall within the concept of ‘service’ contained within the EC Treaty. The conclusions 
of the report led directly to the reform of policy, effective from 1 July 2000. This reform allowed 
general and specialist medical treatment for persons insured under Group 2, as well as dental 
assistance, physiotherapy, and chiropractic treatments for all insured persons, to be purchased 
abroad with subsequent fixed-price reimbursement from the relevant Danish institutions (The policy 
reform entered into force by law no. 467 of 31 May 2000 and BEK no. 536 of 15 June 2000). 
 
While Denmark took this initial step to respond to developments in ECJ case law concerning 
healthcare goods and services outside the hospital sector, domestic reforms and initiatives, were 
also moving along similar lines. As shown in section 4 above, these national reforms introduced a 
greater element of market competition into demand for healthcare by increasing patient choice, 
while at the same time centralising governance and control of supply. These processes have also 
facilitated the introduction of the dynamics of Europeanization into the hospital sector.  
    
Denmark took an active stance in the subsequent case of Geraets-Smits and Peerbooms, being 
among the governments that intervened to give an opinion. The Danish opinion restated the 
conclusions of the Decker/Kohll report (Interview, Danish Ministry of Health, 3 April 2001) that, 
due to the absence of remuneration, hospital treatment did not constitute a service within the 
meaning of Treaty Article 50 (Report for the Hearing, pp. 76-77). Beyond making this point, 
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Denmark argued that another precondition for a service to be Treaty-related was that it must be 
provided with a view to making a profit (Report for the Hearing, p. 78). 
 
The Court, however, disagreed with these observations and extended the understanding of 
‘remuneration’ in Treaty Article 50 to include indirect payments such as those transferred by social 
security funds to cover healthcare costs (Hatzopoulos, 2002, p. 693). Thus the Court’s interpretation 
directly overruled the Danish definition of ‘service’.  
 
As discussed in section 4 above, ‘extended free choice’, effective from 1 July 2002, provides 
Danish patients with a right to treatment outside contracted public hospitals in the event that these 
hospitals cannot provide the necessary treatment within two months. As of October 2007, the 
waiting time guarantee will be further reduced to only one month. The intention of the policy 
reform is to reduce waiting lists and, at the same time, ensure patients a degree of choice if the 
service provided within the public health sector is insufficient. This reform institutionalised the 
obligation to refer patients to non-contracted healthcare providers in the event that care cannot be 
provided by the public sector within the specified waiting time guarantee. However, the freedom to 
reform national healthcare policy had already been restricted by the ECJ 2001 judicial ruling, where 
the Court clarified that the principle of non-discrimination means that once a treatment cannot be 
provided by the contracted national provider, the member state must not favour a nationally 
established, non-contracted, i.e. private, provider over a provider in another member state. The 
Danish proposal for reform directly referred to, and thus, at least in part, took account of the 
reasoning in the Smits-Peerbooms judgement. (Legislative proposal L 64, proposed 29 January 
2002. Adopted 19 March 2002). The ECJ ruling thus impacted on Danish healthcare by granting a 
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different exit opportunity other than private supply, i.e. healthcare supply outside the national 
border.  
 
In this way, the degree of congruence between supranational steps toward integration and domestic 
change directly promoted further Europeanization. Although the decision to treat Danish private 
hospitals equally with hospitals in other member states represents a significant change, it is 
important to note that Denmark’s implementation of the principles of the internal market in 
healthcare is nevertheless limited. The patient has not been granted the right to freely choose a 
foreign hospital whenever ‘undue delay’ of a publicly provided treatment occurs. The ‘free choice’ 
is restricted to those private and foreign hospitals with which the competent Danish institution has 
concluded an agreement (Indenrigs- og Sundhedsministeriet: “Frit Valg af Sygehus”). The 
Association for Danish Regions lists the private and foreign hospitals to which ‘free choice’ has 
been extended and with which an agreement has been concluded 
(http://www.sygehusvalg.dk/geoomraade.aspx). While 166 private hospitals or clinics in Denmark 
are listed, only 7 foreign hospitals or clinics are included, of which 3 are hospitals established in 
Germany, 2 in Sweden, 1 in Spain and 1 is a German hospital established in Denmark (as of April 
2007). In practice, the condition that an agreement has to be concluded beforehand means that 
foreign hospitals are not treated on an equal footing with Danish private ones, and free movement 
of services has not been institutionalised when contracted hospitals in Denmark cannot provide 
treatment without undue delay. The central argument for restricting treatment to contracted foreign 
providers only, is that this allows the Danish authorities to exercise control over the quality of 
provision through prior assessment of overseas facilities. 
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The requirement that foreign hospitals must have signed service agreements is not the only 
restrictive Danish response to the development of ECJ case law. The Danish government recently 
restated its interpretation of the concept of ‘service’ within the meaning of the Treaty (answer to 
Parliamentary question no. 89, 28 June 2005) - that a service within the meaning of the Treaty is 
one that is carried out in return for remuneration and qualifies only when the insured person pays 
more than half of the healthcare costs. The Danish government thus maintains the definition of 
service that it formulated in the wake of the Decker/Kohll judgement and which exempts most 
Danish healthcare services from the impact of the principles of the internal market.  
 
The day after the Watts judgement was delivered, the Danish Minister of Interior and Health was 
asked by an MP to clarify the impact of the judgement on Danish healthcare (answers to 
parliamentary questions no. 4965, 4967 and 4969, 17 May 2006). The government viewpoint is that 
due to the waiting time guarantee, which will be lowered to one month by October 2007, the 
judgement will not have any practical effect. The answers to the parliamentary questions, however, 
again repeat the Danish restrictive definition of service - that a service, within the meaning of the 
Treaty, is one provided with the intention to make a profit where the insured person pays more than 
half of the costs (answer to S 4967, 17 May 2006). It is remarkable that the Danish government 
continue to contradict what has been clarified and repeated by the ECJ. This substantiates that 
opposition may manifest in (the lack of) implementation.    
 
It is clear that in the view of the Danish executive there are, at least, two conceptions of service - 
public services; and services within the meaning of the Treaty, with a private element. However, the 
boundary between the public and the private elements has been moved by the Court so that the 
restrictive Danish interpretation is not now compatible with that set out in the Watts case.  
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Thus while ECJ judgements on health services have, so far, had a limited influence on Danish 
healthcare policies, further impacts can be expected. It is likely that these impacts will be felt in the 
following areas:  
 
 The restrictive Danish interpretation of the concept of a service is not compatible with the 
interpretations of the ECJ. This suggests that the Danish reform of 2000 in response to the 
Decker and Kohll judgements is far from in line with the current status of EC law. 
 The requirement for prior authorisation is an unjustifiable barrier to the free movement of non-
hospital services as treatment is increasingly carried out without the need for hospitalisation. 
The restrictive list of healthcare goods and services which the reform of 2000 allows to be 
purchased outside of the Danish healthcare sector without prior authorisation should be 
extended to the whole spectrum of non-hospital care in order to become compatible with 
evolving Community law.  
 The requirement in Danish legislation that a patient facing undue delay who chooses to be 
treated outside the contracted Danish healthcare sector is restricted to hospitals with which an 
agreement has been concluded beforehand clearly conflicts with the Court’s interpretation of the 
principles of free movement. Furthermore, the condition produces de facto discriminatory 
effects between private Danish hospitals and hospitals in other member states.   
 Finally, the principles of the internal market challenge national control over the supply and 
distribution of medical products. Medicine purchased in other member states and through the 
internet are outcomes of these developments, but give rise, in turn, to questions concerning how 
quality can be ensured while avoiding distortion of competition due to the enforcement of 
national standards. 
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The contours of healthcare services within a political union based on the rule of law and guided by 
principles of free movement can already be identified. Their further evolution depends on the 
response to these developments by European citizens, private interests and national courts. A 
supportive institutional structure to expand European rights is already in place, essentially based on 
new cross-border exit and voice opportunities. Unless member state’s policy makers act in consort 
to de-institutionalise the emerging internal healthcare market, future healthcare governance will 
continue its process of Europeanization.  
 
7. Concluding Remarks 
Although diffuse, the EU impacts on NHS systems are many and far-reaching. The more significant 
effects are the re-structured boundaries for the organisation of the policy field; an increased 
obligation for the member states to integrate foreign suppliers into the domestic healthcare mix; and 
a de-structuring of the traditional tools of governance.  
 
The process involved in the Europeanization of Danish healthcare has been transmitted by two 
types of mediating factors. The Danish administration has played a key role, since it has constituted 
the most significant veto-point in the process, occupying the space of control through which the ECJ 
decisions have been re-interpreted and ‘translated’. On the one hand, the administration has allowed 
a certain impact. At first glance, it has proven its reputation as complier with EU obligations 
(Falkner et al. 2005). On the other hand, it has attempted to steer and reduce the effects of the EU 
on Danish healthcare. The administration has defended its discretionary scope by maintaining a 
definition of service, which de facto goes against the definition developed by the ECJ. In this way, 
impact has been reduced. Furthermore, its implementation of the new exit option to allow foreign 
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treatment to patients if they cannot be treated nationally without ‘undue delay’, i.e. 2 months as of 
now (one month as of October 2007), is not simply the implementation of unrestricted free choice.  
Through the means of contracts, control remains in the hand of the Danish administration, and de 
facto foreign hospitals are not treated equally with private and public hospitals established in 
Denmark.  
 
The manner in which the Danish executive exercises its veto-point through a creative and 
autonomy-preserving re-interpretation of the meaning of ECJ decisions comes to limit the full 
impact of EU integration. Nevertheless, the other mediating factor, domestic healthcare reforms, 
introduces new principles in Danish healthcare governance. This indeed propels Europeanization, as 
the congruence between the paths of national reforms and that of EU healthcare integration is high. 
Free choice of hospital, waiting time guarantees, the free movement of Union citizens and services 
and an intensified focus on patient rights all go hand-in-hand and facilitate the Europeanization 
process.  
 
The concrete impact is a result of these two contradicting mediating factors. Among the impacts are 
legislative amendments integrating both non-hospital and hospital foreign supplies, thus indeed re-
structuring the traditional boundaries of Danish healthcare. The principle of territoriality as a tool of 
healthcare governance has been compromised, and its future legitimate exercise is called into 
question by the supranational polity. This has significant implications for governance. Whereas the 
state and counties traditionally controlled the supply – and thus the organisation and quality of 
healthcare – free choice introduces a very different logic of governance. Free choice has a clear 
analogy to the market, and its logic is backed up by patient rights. The customer, i.e. the patient, 
decides. And via an EU exit opportunity, the healthcare market will become immense as compared 
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with the national healthcare systems of the present – when the member states implement their 
European obligation in full scope. Furthermore, the EU polity provides the Union citizen with 
voice, should her rights be violated. Not only can the Union citizen rely on the EU judicial system, 
but the interpretations of the ECJ oblige the member states to administer EU rights transparently, 
objectively and provide appeal structures if the welfare supply of other member states is denied. 
Against this background, it is also clear that the governance tool of administrative discretion is 
severely challenged. Exit opportunities, as supported by EU-institutionalised voice (Hirschman 
1970; Ferrera 2005; Bartolini 2005), de-structure the traditional means of healthcare governance, 
and the logic introduced places the ultimate (and smallest) unit in the system in focus: the EU 
citizen, the patient, the welfare consumer. Their (free) welfare movements may prove difficult to 
govern. In spite of healthcare as a ‘less likely’ case of Europeanization, impact goes beyond the 
light mode of absorption. Healthcare is being made to accommodate the European principles 
affecting the traditional means of governance and organisation. Future impact may scale beyond 
accommodation. We may witness the formation of a different institutional legacy, initiating a 
Europeanised healthcare model. A model emerging around a new set of stakeholders, principles and 
structures, which includes the market, principles of free movement, patient choice and patient rights 
institutionalised and safeguarded by the EU.    
 
ACKNOWLEDGEMENTS 
We would like to thank research assistant Mads Christian Dagnis Jensen for carrying out the 
quantitative research and constructing the database on the extent to which Danish national 
healthcare policy has been influenced by, or referred to, EU law (see Section 3 in the above). An 
annex detailing the various Danish laws referring to EU law can be obtained upon request.  
 
 29 
References 
Bartolini, S. (2005) Restructuring Europe. Center Formation, System Building and Political 
Structuring between the Nation State and the EU, Oxford: Oxford University Press. 
 
Börzel, T. 1999. ‘Towards Convergence in Europe? Institutional Adaptation to Europeanization in 
Germany and Spain’. Journal of Common Market Studies, 37, 4, 573-96. 
 
Börzel, T. 2005. ‘Europeanization: How the European Union Interacts with its Member States’ in 
Bulmer, S., and C. Lequesne (eds.), The Member States of the European Union. Oxford: Oxford 
University Press, pp. 45-77. 
 
Bulmer, S., and Radaelli, C. 2005. ‘The Europeanization of National Politics’ in Bulmer, S., and C. 
Lequesne (eds.), The Member States of the European Union. Oxford: Oxford University Press, pp. 
338-60.   
 
Checkel, J. 2005. ’It’s the Process Stupid! Process Tracing in the Study of European and 
International Politics’. ARENA working paper, 26.  
 
Cornelissen, R. 1996. ’The Principle of Territoriality and the Community Regulations on Social 
Security (Regulations 1408/71 and 574/72)’ Common Market Law Review 33, 439-71.  
 
De Búrca, G. 2005. ‘Rethinking law in neofunctionalist theory’ Journal of European Public Policy 
12:2, 1-17 
 
 30 
Falkner, G. O. Treib, M. Hartlapp and S. Leiber. 2005. Complying with Europe. EU Harmonisation 
and Soft Law in the Member State. Cambridge: Cambridge University Press.  
 
Ferrera, M. 2005. The Boundaries of Welfare. European Integration and the New Spatial Politics of 
Social Protection. Oxford: Oxford University Press.  
 
Hatzopoulos, V. 2002. ‘Killing National Health and Insurance Systems but Healing Patients? The 
European Market for Health Care Services after the Judgments of the ECJ in Vanbraekel and 
Peerbooms’. Common Market Law Review, 39, 683-729. 
 
Haverland, M. 2000. ‘National adaptation to European integration: The importance of institutional 
veto points’, Journal of Public Policy, 20, 1, 83-103 
 
Hirschman, A. O. 1970. Exit, Voice and Loyalty. Cambridge, MA: Harvard University Press.  
 
Martinsen, D. S. 2005. ‘The Europeanization of Welfare – the Domestic impact of Intra-European 
Social Security’, Journal of Common Market Studies, 43, 5, 1003-30.  
 
Martinsen, D. S. 2005b. ‘Towards an Internal Health Market with the European Court’. West 
European Politics, 28, 5, 1035-56.  
 
Mattli, W. and A-M. Slaughter 1998. ‘Revisiting the European Court of Justice’. International Organization, 
52,1, 177-209. 
 
 
 31 
Pedersen K. M., M. Beck, and T. Christiansen. 2005. ‘The Danish health care system evolution - 
not resolution - in a decentralized system’, Health Economics, 14, 1, 41-57. 
 
Permanand, G., and E. Mossialos. 2005. ‘Constitutional asymmetry and pharmaceutical policy-
making in the European Union’, Journal of European Public Policy 12, 4, 687-709.  
 
Radelli, C.M. 2003. ‘The Europeanization of Public Policy’. In K. Featherstone and C. Radaelli 
(eds), The Politics of Europeanization. Oxford: Oxford University Press, pp. 27-57.  
 
Salomonsen, H. 2005. ’Udviklingen i den statslige styring af sygehusvæsenet: Økonomiaftaler og 
ministeriets rolle’ Forskningsrapport. FLOS og Center for Health Management. Copenhagen: 
Copenhagen Business School.  
 
Saltman, R., V. Bankauskaite and K. Vrangbæk. 2007. Decentralization in Health Care. Strategies 
and Outcomes. London: Open University Press.   
 
Schmidt, V. 2002. ‘Europeanization and the Mechanics of Economic Policy Adjustment’. Journal 
of European Public Policy, 9,6, 894-915 
 
Stone Sweet, A., Sandholtz, W., and N. Fligstein. 2001 (eds.) The Institutionalization of Europe. 
Oxford: Oxford University Press.  
 
Vrangbæk, K. and D. Martinsen. 2005. ’Sporskifte i dansk sundhedspolitik?’ Økonomi og Politik 
78, 18-31. 
 32 
 
Vrangbæk, K. 1999. ’Markedsorientering i sygehussektoren’. Ph.d. afhandling. København: Institut 
for Statskundskab. 
 
Vrangbæk, K., and T. Christiansen. 2005. ‘Health policy in Denmark: leaving the decentralized 
welfare path?’ Journal of Health Politics, Policy and Law, 30, 1-2, 29-52. 
 
 
 
